{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:25:17Z","timestamp":1789979117968,"version":"4.0.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.diagmicrobio.2018.06.015","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T23:23:28Z","timestamp":1530141808000},"page":"305-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["The stability of antimycobacterial drugs in media used for drug susceptibility testing"],"prefix":"10.1016","volume":"92","author":[{"given":"Esther L.M.","family":"Schoutrop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.E.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josien C.A.","family":"Jenniskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz E.","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.","family":"Mouton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob E.","family":"Aarnoutse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakko","family":"van Ingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0005","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2165\/11532080-000000000-00000","article-title":"Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients","volume":"49","author":"Alffenaar","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0010","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1469-0691.2011.03551.x","article-title":"The ins and outs of Mycobacterium tuberculosis drug susceptibility testing","volume":"17","author":"B\u00f6ttger","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0015","series-title":"CLSI document M24-A2","article-title":"Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes \u2013 Approved standard","author":"Clinical Laboratory Standards Institute (CLSI)","year":"2011"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0732-8893(87)90165-9","article-title":"In vitro susceptibility of Mycobacterium avium complex to antibacterial agents","volume":"8","author":"Davis","year":"1987","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0025","first-page":"2838","article-title":"Time-kill kinetics of slowly-growing mycobacteria common in pulmonary disease","volume":"70","author":"Ferro","year":"2015"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/jac\/dku431","article-title":"Time-kill kinetics of antibiotics active against rapidly growing mycobacteria","volume":"70","author":"Ferro","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0035","doi-asserted-by":"crossref","first-page":"16004","DOI":"10.1073\/pnas.1214188109","article-title":"Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials","volume":"109","author":"Gold","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0040","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/AAC.36.11.2398","article-title":"Stability of antimycobacterial drugs in susceptibility testing","volume":"36","author":"Griffith","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0050","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2217\/fmb.14.60","article-title":"Drug susceptibility testing of nontuberculous mycobacteria","volume":"9","author":"van Ingen","year":"2014","journal-title":"Future Microbiol"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0055","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1164\/rccm.201204-0682OC","article-title":"The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment","volume":"186","author":"van Ingen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0060","first-page":"272","article-title":"Rifampin: in vitro effect on atypical mycobacteria","volume":"104","author":"Rynearson","year":"1971","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0065","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/jac\/dkq374","article-title":"Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis","volume":"65","author":"de Steenwinkel","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0070","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1128\/AAC.20.5.610","article-title":"Susceptibility of Mycobacterium marinum to tetracyclines and aminoglycosides","volume":"20","author":"Wallace","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0075","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0962-8479(92)90145-A","article-title":"In vitro activity of meropenem and imipenem against mycobacteria: development of a daily antibiotic dosing schedule","volume":"73","author":"Watt","year":"1992","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0080","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/JCM.01951-10","article-title":"Rifampicin stability in 7H9 broth and Lowenstein-Jensen medium","volume":"49","author":"Yu","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2018.06.015_bb0085","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMra1200894","article-title":"Tuberculosis","volume":"368","author":"Zumla","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318302141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318302141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T23:22:45Z","timestamp":1542064965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889318302141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0732889318302141"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.06.015","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The stability of antimycobacterial drugs in media used for drug susceptibility testing","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}